New antibody tested in fight against deadly heart shock
Disease control
Recruiting now
This study is testing a new antibody drug called procizumab in patients with cardiogenic shock, a life-threatening condition where the heart suddenly can't pump enough blood. The main goal is to see if the drug is safe and to find the right dose for future testing. It will involv…
Phase: PHASE1, PHASE2 • Sponsor: 4TEEN4 Pharmaceuticals GmbH • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC